ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2323

A Genetic Polymorphism on New Zealand Black Chromosome 1 Is Associated with Abnormal Dendritic Cell Function Leading to Expansion of TH1, TH17 and T Follicular Helper (TFH) Cells

Nafiseh Talaei1, Carolina Landolt-Marticorena2, Babak Noamani1, Evelyn Pau3, Nan-Hua Chang4 and Joan E. Wither5, 1Genetics and developmental biology, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 2Rheumatology, University Health Network, Toronto, ON, Canada, 3Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 4Genetics and Development, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 51E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, dendritic cells and systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Email
  • Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: We have previously shown that B6 mice with an introgressed homozygous New Zealand Black chromosome (c) 1 interval (70 to 100 cM) develop high titres of antinuclear antibodies and severe glomerulonephritis (GN), with approximately 40% of the mice dying by 8 months age.  Using subcongenic mice with shorter intervals in this region we found that expansion of TH1, TH17, and TFH cell populations was closely associated with the severity of GN.  We further showed, using ovalbumin (OVA) as an exogenous antigen, that this was an intrinsic aspect of their immune system, resulting from a combination of T and non-T cell defects. In this report, we have investigated the role of dendritic cells (DC) in this expansion.

Methods: OVA-specific T cells from B6 or c1(70-100), c1(88-100), or c1(96-100) congenic OT-II TCR transgenic mice were adoptively transferred into B6.Thy1.1 or c1(70-100).Thy1.1 mice.  Mice were immunized with OVA emulsified in CFA, sacrificed 2 weeks later, and the proportion of various splenic T cell subsets determined by flow cytometry, gating separately on Thy1.1+ (recipient) and Thy1.2+(transferred) T cells. Bone marrow-derived dendritic cells (DC) isolated from 8wk old c1(70-100), c1(88-100) and c1(96-100) congenic, and B6 control mice were cultured in the presence of LPS, imiquimod or CpG, or pulsed with OVA and co-cultured with naïve OT-II T cells. Production of cytokines (IL-12, IL-23, IL-6) by stimulated DC was analyzed by ELISA or flow cytometry. 

Results: Adoptive transfer experiments revealed that the increased IFN-γ and IL-17 secreting cell differentiation in c1(70-100) congenic mice arises in part from intrinsic T cell defects localizing to the NZB c1 96-100 cM and 88-96 cM intervals, respectively. However, OT-II T cells from all mouse strains examined demonstrated enhanced differentiation to TH1, TH17, and TFHpopulations when transferred into c1(70-100).Thy1.1 as compared to B6.Thy1.1 mice.  This finding suggested that the increased differentiation of these T cell subsets in c1 congenic mice was also dependent upon cellular and/or cytokine cues provided by the c1(70-100) environment.  Since, DC play an important role in the antigen presentation and cytokine secretion that directs T cell responses, DC function was contrasted in the various mouse strains.  Following TLR stimulation, DC from c1(70-100) mice expressed significantly higher levels of MHC and co-stimulatory molecules, and  secreted higher amounts of  pro-inflammatory cytokines such as  IL-6 and  IL-12.  Consistent with altered DC function, OVA-pulsed DC from c1(70-100) mice induced significantly increased differentiation of naïve OT-II cells to IFN-γ, IL-17 or IL-21 secreting cells as compared to B6 DC.   

Conclusion: Our results suggest that a genetic polymorphism in the 70-88 cM interval of NZB c1 congenic mice alters DC function and acts together with intrinsic T cell defects to promote the expansion of TH1, TH17 and TFH cells in c1(70-100) mice, resulting in severe GN.


Disclosure:

N. Talaei,
None;

C. Landolt-Marticorena,
None;

B. Noamani,
None;

E. Pau,
None;

N. H. Chang,
None;

J. E. Wither,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-genetic-polymorphism-on-new-zealand-black-chromosome-1-is-associated-with-abnormal-dendritic-cell-function-leading-to-expansion-of-th1-th17-and-t-follicular-helper-tfh-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology